Literature DB >> 3219260

A hybrid bioartificial liver composed of multiplated hepatocyte monolayers.

J Uchino1, T Tsuburaya, F Kumagai, T Hase, T Hamada, T Komai, A Funatsu, E Hashimura, K Nakamura, T Kon.   

Abstract

Monolayer cultures of hepatocytes were shown to have good function when compared with suspended cells. The authors manufactured a new hybrid artificial liver containing hepatocyte monolayers and evaluated its function. Hepatocytes isolated from an adult dog liver were cultured on collagen coated borosilicated glass (10 X 20 X 0.04 cm). A long-stroke artificial liver module was constructed by stacking 200 glass plates bearing hepatocytes, which were viable and functioned well during 4 weeks in perfusion culture; glyconeogenesis = 110 ng/micrograms DNA/min, urea synthesis = 3.6 ng/micrograms DNA/min and albumin synthesis = 29 micrograms/10(6) cells/day at the 5th day of perfusion. The levels were maintained for 2 weeks. The new device was applied to anhepatic dogs (Group 3) and compared with untreated (Group 1) and plasma exchange dogs (Group 2). The survival times were 21.3 +/- 5.6 hours in Group 1 (N = 6), 27.8 +/- 4.0 hours in Group 2 (N = 3), and 55.0 +/- 10.3 hours in Group 3 (N = 4). The longest survival was 65 hours. Serum ammonia increased to over 2,000 micrograms/dl after 12 hours in Groups 1 and 2, but remained under 400 micrograms/dl in Group 3. This new type of hybrid system may be a pilot design for the complete artificial liver.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219260

Source DB:  PubMed          Journal:  ASAIO Trans        ISSN: 0889-7190


  18 in total

Review 1.  Extracorporeal perfusion for the treatment of acute liver failure.

Authors:  H B Stockmann; C A Hiemstra; R L Marquet; J N IJzermans
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

2.  Microgravity as a means to incorporate HepG2 aggregates in polysaccharide-protein hybrid scaffold.

Authors:  P R Sarika; Nirmala Rachel James; P R Anilkumar; Deepa K Raj; T V Kumary
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

Review 3.  Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.

Authors:  Katsutoshi Naruse; Wei Tang; Masatoshi Makuuch
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

4.  The effectiveness of a novel cartridge-based bioreactor design in supporting liver cells.

Authors:  Mei Niu; Paul Hammond; Robin N Coger
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

Review 5.  Generating intestinal tissue from stem cells: potential for research and therapy.

Authors:  Jonathan C Howell; James M Wells
Journal:  Regen Med       Date:  2011-11       Impact factor: 3.806

Review 6.  Bioreactor technologies to support liver function in vitro.

Authors:  Mohammad R Ebrahimkhani; Jaclyn A Shepard Neiman; Micha Sam B Raredon; David J Hughes; Linda G Griffith
Journal:  Adv Drug Deliv Rev       Date:  2014-03-05       Impact factor: 15.470

Review 7.  Artificial liver support: future aspects.

Authors:  Katsutoshi Naruse
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

8.  Culturing of primary hepatocytes as entrapped aggregates in a packed bed bioreactor: a potential bioartificial liver.

Authors:  A P Li; G Barker; D Beck; S Colburn; R Monsell; C Pellegrin
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

Review 9.  Artificial livers--what's keeping them?

Authors:  E Davies; H J Hodgson
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

10.  New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy.

Authors:  Luiz Anastácio Alves; André Bonavita; Kátia Quaresma; Elenilde Torres; Paulo Anastácio Furtado Pacheco; Vinícius Cotta-de-Almeida; Roberto Magalhães Saraiva
Journal:  Cell Med       Date:  2010-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.